Skip to main content
Log in

QOL similarly enhanced in lupus nephritis with different treatments

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Grootscholten C, Snoek FJ, Bijl M, van Houwelingen HC, Derksen RHWM, Berden JHM, Dutch Working Party on SLE.Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/methylprednisolone in a randomized controlled trial. The Journal of Rheumatology 34: 1699-1707, No. 8, Aug 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

QOL similarly enhanced in lupus nephritis with different treatments. Pharmacoecon. Outcomes News 538, 10 (2007). https://doi.org/10.2165/00151234-200705380-00022

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705380-00022

Keywords

Navigation